CHOICE Awards names 40 finalists for 2026 beauty and longevity prizes

The International Longevity Science Council and a global judging panel have unveiled 40 finalists for the 2026 Beauty & Longevity CHOICE Awards, with winners set for Miami in February 2027. The awards highlight a shift from cosmetic claims to evidence-backed skin, hair, diagnostics and longevity technologies.

Why it matters: - The finalist list shows beauty and wellness brands moving toward clinical proof, biomarker science and longevity-focused product design. - The awards are designed to reward evidence, not marketing, which raises the bar for brands seeking credibility with investors, clinicians and consumers. - The winners will be announced in Miami on Feb. 10, 2027, making the contest a live benchmark for a fast-growing category.

What happened: - The International Longevity Science Council and a global judging panel announced the official finalists for the 2026 Beauty & Longevity CHOICE Awards on Sept. 14, 2026, in Zurich. - Forty finalists were selected from hundreds of international submissions across 11 categories. - The finalists include brands, clinics and deep-tech platforms working on skin, hair, diagnostics, wearables and systemic longevity.

The details: - Each entry was scored on a 100-point evidence ladder built around a four-tier framework, from mechanistic rationale to published, product-specific human clinical data. - Judges declared conflicts of interest and recused themselves when needed. - Finalists were ranked on evidence strength, not marketing spend. - Skin and hair finalists include Eyes Are The Story / ESSIRI Labs, Lancaster Monaco, Acaderma, INSTYTUTUM, Proya Cosmetics, Rose Code, Beekman 1802, Comfort Zone, Plated Skin Science, Dr Dennis Gross Skincare, PROVOQUE by LevEllis, Sherak, Olebiome, BEMY Cosmetics, K18 Hair, Elixr and NNP Laboratories. - Systemic and inside-out longevity finalists include TELOSTIM, Gundry MD, Good Bacteria, NOVOS, Epillon, L'evive Labs and Bronn BV. - Diagnostics, wearables and deep-tech finalists include BioAgeDiagnostics, Dr Dennis Gross Skincare, Joylux, NeuraLed, Mitolux, Antarka, dsm-firmenich Ltd, Geltor, AOXP and Symrise. - Longevity clinic and systems-brand finalists include Henri Chenot International, AYUN, CHAUM Longevity Clinic, Longevity Center Switzerland, SkyLab AG and Ayuna. - The awards program is part of INNOCOS executive summits and business tours that bring founders, scientists, investors and jury members together. - Upcoming INNOCOS stops include Miami on Feb. 10-12, Nice on April 5-6, Shanghai on May 9-12, London on June 30-July 2, Zurich on Sept. 7-9 and San Francisco on Sept. 28-30. - Nominations are open for the Longevity100 list, which will be celebrated on the opening evening of INNOCOS London on June 30, 2027.

Between the lines: - The competition reflects a broader industry shift from topical beauty positioning toward measurable healthspan and cellular-aging claims. - The emphasis on published clinical evidence and product-specific data suggests the awards are trying to separate scientific validation from category hype. - The inclusion of diagnostics, wearables and biotech infrastructure signals that longevity beauty is becoming a platform business, not just a product segment.

What's next: - Winners will be revealed at the CHOICE Awards Gala in Miami in February 2027. - The awards program continues with additional INNOCOS events across Europe, Asia and the U.S. through 2027. - The Longevity100 nominations remain open for leaders, scientists and founders in beauty, wellness and longevity.

The bottom line: - The 2026 finalist slate shows beauty and longevity brands increasingly being judged like science companies, with proof now carrying more weight than promotion.